BioShield Stakeholders Workshop: General Session Webcasts and Presentations

PLENARY SESSION:

View the webcast of all of the Plenary session from 25 September 2006

 OPENING SESSION:

Welcome and Introduction of the Assistant Secretary for Public Health Emergency Preparedness by Carol Linden, Acting Principal Deputy Director of the Office of Public Health Emergency Medical Countermeasures, Office of Public Health Emergency Preparedness, Department of Health and Human Services

Introduction of the Secretary by RADM Craig Vanderwagen, Assistant Secretary for Public Health Emergency Preparedness, Department of Health and Human Services

Secretary Michael O. Leavitt, Department of Health and Human Services

Dr. Rajeev Venkayya, Special Assistant to the President for Biodefense, Homeland Security Council, Executive Office of the Present: [Slides in PDF – 113KB]**

Ms. Ellen Embrey, Deputy Assistant Secretary of Defense Force Health Protection and Readiness, Department of Defense: [Slides in PDF- 307KB]**

 SESSION I:

Introduction to Session 1 Speakers by Dr. Carol Linden, Acting Principal Deputy Director, Office of Public Health Emergency Medical Countermeasures, Office of Public Health Emergency Preparedness, Department of Health and Human Services

Introduction to HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) and the PHEMCE Strategy by RADM Craig Vanderwagen, Assistant Secretary for Public Health Emergency Preparedness: [Slides in PDF – 861KB]**

Dr. Elias A. Zerhouni, Director, National Institutes of Health, Department of Health and Human Services: [Slides in PDF – 6,161KB]**

Dr. Julie L. Gerberding, Director, Centers for Disease Control and Prevention, Department of Health and Human Services: [Slides in PDF - 12.76MB]**

Dr. Andrew C. von Eschenbach. Acting Commissioner, Food and Drug Administration, Department of Health and Human Services

 PANEL I:
INDUSTRY

Introductory Remarks by Dr. Monique K. Mansoura, Acting Deputy Director for Policy, Planning and Requirements, Office of Public Health Emergency Medical Countermeasures, Office of Public Health Emergency Preparedness, Department of Health and Human Services

Chris Colwell, Director, Healthcare Regulatory Affairs, Biotechnology Industry Organization (BIO): [Slides in PDF - 78KB]**

Tom McKenna, Chair, Health Emergency Response Group, Pharmaceutical Research and Manufacturers of America (PhRMA): [Slides in PDF – 245KB]**

Mark Leahey, Executive Director, Medical device Manufacturers Association

Janet Trunzo, Executive Vice President for Technology and Regulatory Affairs, AdvaMed: [Slides in PDF – 19KB]**

 PANEL II:
ACADEMIA AND
SCIENCE

Introductory Remarks by DrCarol Linden, Acting Principle Deputy Director of the Office of Public Health Emergency Medical Countermeasures, Office of Public Health Emergency Preparedness, Department of Health and Human Services

Dr. Tara O’Toole, CEO and Director, the Center for BioSecurity of the University of Pittsburgh Medical Center

Dr. Debra Anderson, Associate Director, Great Lakes Biodefense Research Center of Excellence: [Slides in PDF – 73KB]**

Dr. Paul Okunieff, Centers for Countermeasures against Radiation and Chairman of the Department of Radiation Oncology, University of Rochester Medical Center: [Slides in PDF – 64KB]**

 PANEL III:
MEDICINE AND
PUBLIC HEALTH

Introductory Remarks by Dr. Gerald Parker, Principle Deputy Assistant Secretary, Office of Public Health Emergency Preparedness

Dr. James J. James, Director, Disaster Preparedness, American Medical Association

Nancy L. Hughes, Director of the Center for Occupational and Environmental Health, American Nurses Association: [Slides in PDF – 166KB]**

Dr. Georges Benjamin, Executive Director, American Public Health Association

Dr. Paul Jarris, Executive Director, Association of State and Territorial Health Officials: [Slides in PDF – 64KB]**

Dr. Michael Frasier, Deputy Executive Director, National Association of County and City Health Officials: [Slides in PDF – 345KB]**

 PLENARY SESSION:

View the webcast of all of the Plenary session from 26 September 2006

 SESSION II:

Welcome and First Day Review by RADM Craig Vanderwagen, Assistant Secretary for Public Health Emergency Preparedness, Department of Health and Human Services

Chemical, Biological, Radiological, and Nuclear Threat Assessments by Dr. John Vitko, Science and Technology Directorate, Department of Homeland Security: [Slides in PDF – 1,903KB]**

Medial/public Health Consequence Modeling by Dr. Peter Highnam, Modeler, Office of Public Health Emergency Medical Countermeasures, Office of Public Health Emergency Preparedness, Department of Health and Human Services: [Slides in PDF – 547KB]**

Medical Countermeasures in a Public Health Emergency by Dr. R. Tom Sizemore III, Acting Deputy Director, Office of Preparedness and Emergency Operations, Office of Public Health Emergency Preparedness, Department of Health and Human Services: [Slides in PDF – 536KB]**

Threat Surveillance/Detection and Medical Countermeasure Utilization and Deployment by CAPT Dan Sosin, Senior Advisor for Science and Public Health Practice, Coordinating Office for Terrorism and Emergency Response, Centers for Disease Control and Prevention, Department of Health and Human Services: [Slides in PDF – 1,416KB]**

Questions and Answers by Session II Panelists

 SESSION III:

Biodefense Research and Development Priorities/Program by Dr. Michael Kurilla, Director, Office of Biodefense Research Activities in the Division of Microbiology and Infectious Diseases, Associate Director for Biodefense Product Development, National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services: [Slides in PDF – 7,435KB]**

FDA’s Role in Biodefense by RADM Boris Lushniak, Assistant Commissioner, Office of Counterterrorism Policy and Planning, Food and Drug Administration, Department of Health and Human Services: [Slides in PDF – 574KB]**

Establishment and Prioritization of Medical Countermeasure Requirements by Dr. Monique K. Mansoura, Acting Deputy Director for Policy, Planning and Requirements, Office of Public Health Emergency Medical Countermeasures, Department of Health and Human Services: [Slides in PDF - 1,754KB]**

Acquisition Process Programs and Policy under Project BioShield: Dr. Carol Linden, Acting Principal Deputy Director, Office of Public Health Emergency Medical Countermeasures, Office of Public Health Emergency Preparedness, Department of Health and Human Services: [Slides in PDF – 510KB]**

Questions and Answers by Session III Panelists

 CLOSING SESSION:

Medical Countermeasure Development and Acquisition— Path Forward under the PHEMCE Strategy by Dr. Carol Linden, Acting Principal Deputy Director, Office of Public Health Emergency Medical Countermeasures, Office of Public Health Emergency Preparedness, Department of Health and Human Services

Closing Remarks by Dr. Gerald Parker, Principal Deputy Assistant Secretary, Office of Public Health Emergency Preparedness, Department of Health and Human Services